Washington, DC, United States of America

Rhonda Flores

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rhonda Flores: Innovator in Cancer Therapy

Introduction: Rhonda Flores is a recognized inventor based in Washington, DC. She has made significant contributions to the field of cancer research, evidenced by her innovative work on anti-CD24 antibodies, which specifically target cancer cells while sparing healthy cells.

Latest Patents: Rhonda holds a patent for "Anti-CD24 compositions and uses thereof." This patent encompasses her pioneering discovery of anti-CD24 antibodies that selectively bind to human CD24 present in cancer cells, facilitating advancements in targeted cancer therapies.

Career Highlights: Rhonda has made her mark in the biotechnology sector through her roles in leading organizations. She has worked at Oncoc4, Inc. and the Children's Research Institute at Children's National Medical Center, where she contributed her expertise in developing innovative solutions for cancer treatment.

Collaborations: Throughout her career, Rhonda has collaborated with esteemed colleagues in the field. Notable coworkers include Yang Liu and Pan Zheng, with whom she has shared insights and expertise, further enhancing her contributions to cancer research.

Conclusion: Rhonda Flores exemplifies the spirit of innovation in the realm of medical research. Her work on anti-CD24 antibodies not only showcases her inventiveness but also holds the potential to transform cancer therapy, offering hope for improved treatment options in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…